ICD-10-CM Code T46: Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system and Related Diagnosis Codes.


The ICD-10-CM (the International Classification of Diseases, Tenth Revision, Clinical Modification) is a standardized coding system used when classifying diseases and medical conditions. Healthcare providers report these codes on Medical claims when diagnosing patient care.

Explore ICD-10-CM codes, organized by chapters based on body systems and medical conditions, as outlined in the International Classification of Diseases, Tenth Revision, Clinical Modification.

Tip: Have a specific ICD-10-CM code? Use our simple to use ICD-10-CM Code Lookup tool.

Eclaims - ICD-10-CM Tabular Code List v1.0.0

A categorized list of ICD-10-CM codes organized by chapters based on body systems or medical conditions, according to the International Classification of Diseases, Tenth Revision, Clinical Modification.

Questions
Results
  • T46 - Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system
    • T46.0 - Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
      • T46.0X - Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
        • T46.0X1 - Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional)
          • T46.0X1A - Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
          • T46.0X1D - Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter
          • T46.0X1S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela
        • T46.0X2 - Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm
          • T46.0X2A - Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
          • T46.0X2D - Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter
          • T46.0X2S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela
        • T46.0X3 - Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault
          • T46.0X3A - Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
          • T46.0X3D - Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter
          • T46.0X3S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela
        • T46.0X4 - Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined
          • T46.0X4A - Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
          • T46.0X4D - Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter
          • T46.0X4S - Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela
        • T46.0X5 - Adverse effect of cardiac-stimulant glycosides and drugs of similar action
          • T46.0X5A - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
          • T46.0X5D - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
          • T46.0X5S - Adverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
        • T46.0X6 - Underdosing of cardiac-stimulant glycosides and drugs of similar action
          • T46.0X6A - Underdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter
          • T46.0X6D - Underdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
          • T46.0X6S - Underdosing of cardiac-stimulant glycosides and drugs of similar action, sequela
    • T46.1 - Poisoning by, adverse effect of and underdosing of calcium-channel blockers
      • T46.1X - Poisoning by, adverse effect of and underdosing of calcium-channel blockers
        • T46.1X1 - Poisoning by calcium-channel blockers, accidental (unintentional)
          • T46.1X1A - Poisoning by calcium-channel blockers, accidental (unintentional), initial encounter
          • T46.1X1D - Poisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter
          • T46.1X1S - Poisoning by calcium-channel blockers, accidental (unintentional), sequela
        • T46.1X2 - Poisoning by calcium-channel blockers, intentional self-harm
          • T46.1X2A - Poisoning by calcium-channel blockers, intentional self-harm, initial encounter
          • T46.1X2D - Poisoning by calcium-channel blockers, intentional self-harm, subsequent encounter
          • T46.1X2S - Poisoning by calcium-channel blockers, intentional self-harm, sequela
        • T46.1X3 - Poisoning by calcium-channel blockers, assault
          • T46.1X3A - Poisoning by calcium-channel blockers, assault, initial encounter
          • T46.1X3D - Poisoning by calcium-channel blockers, assault, subsequent encounter
          • T46.1X3S - Poisoning by calcium-channel blockers, assault, sequela
        • T46.1X4 - Poisoning by calcium-channel blockers, undetermined
          • T46.1X4A - Poisoning by calcium-channel blockers, undetermined, initial encounter
          • T46.1X4D - Poisoning by calcium-channel blockers, undetermined, subsequent encounter
          • T46.1X4S - Poisoning by calcium-channel blockers, undetermined, sequela
        • T46.1X5 - Adverse effect of calcium-channel blockers
          • T46.1X5A - Adverse effect of calcium-channel blockers, initial encounter
          • T46.1X5D - Adverse effect of calcium-channel blockers, subsequent encounter
          • T46.1X5S - Adverse effect of calcium-channel blockers, sequela
        • T46.1X6 - Underdosing of calcium-channel blockers
          • T46.1X6A - Underdosing of calcium-channel blockers, initial encounter
          • T46.1X6D - Underdosing of calcium-channel blockers, subsequent encounter
          • T46.1X6S - Underdosing of calcium-channel blockers, sequela
    • T46.2 - Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs, not elsewhere classified
      • T46.2X - Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs
        • T46.2X1 - Poisoning by other antidysrhythmic drugs, accidental (unintentional)
          • T46.2X1A - Poisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter
          • T46.2X1D - Poisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter
          • T46.2X1S - Poisoning by other antidysrhythmic drugs, accidental (unintentional), sequela
        • T46.2X2 - Poisoning by other antidysrhythmic drugs, intentional self-harm
          • T46.2X2A - Poisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter
          • T46.2X2D - Poisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter
          • T46.2X2S - Poisoning by other antidysrhythmic drugs, intentional self-harm, sequela
        • T46.2X3 - Poisoning by other antidysrhythmic drugs, assault
          • T46.2X3A - Poisoning by other antidysrhythmic drugs, assault, initial encounter
          • T46.2X3D - Poisoning by other antidysrhythmic drugs, assault, subsequent encounter
          • T46.2X3S - Poisoning by other antidysrhythmic drugs, assault, sequela
        • T46.2X4 - Poisoning by other antidysrhythmic drugs, undetermined
          • T46.2X4A - Poisoning by other antidysrhythmic drugs, undetermined, initial encounter
          • T46.2X4D - Poisoning by other antidysrhythmic drugs, undetermined, subsequent encounter
          • T46.2X4S - Poisoning by other antidysrhythmic drugs, undetermined, sequela
        • T46.2X5 - Adverse effect of other antidysrhythmic drugs
          • T46.2X5A - Adverse effect of other antidysrhythmic drugs, initial encounter
          • T46.2X5D - Adverse effect of other antidysrhythmic drugs, subsequent encounter
          • T46.2X5S - Adverse effect of other antidysrhythmic drugs, sequela
        • T46.2X6 - Underdosing of other antidysrhythmic drugs
          • T46.2X6A - Underdosing of other antidysrhythmic drugs, initial encounter
          • T46.2X6D - Underdosing of other antidysrhythmic drugs, subsequent encounter
          • T46.2X6S - Underdosing of other antidysrhythmic drugs, sequela
    • T46.3 - Poisoning by, adverse effect of and underdosing of coronary vasodilators
      • T46.3X - Poisoning by, adverse effect of and underdosing of coronary vasodilators
        • T46.3X1 - Poisoning by coronary vasodilators, accidental (unintentional)
          • T46.3X1A - Poisoning by coronary vasodilators, accidental (unintentional), initial encounter
          • T46.3X1D - Poisoning by coronary vasodilators, accidental (unintentional), subsequent encounter
          • T46.3X1S - Poisoning by coronary vasodilators, accidental (unintentional), sequela
        • T46.3X2 - Poisoning by coronary vasodilators, intentional self-harm
          • T46.3X2A - Poisoning by coronary vasodilators, intentional self-harm, initial encounter
          • T46.3X2D - Poisoning by coronary vasodilators, intentional self-harm, subsequent encounter
          • T46.3X2S - Poisoning by coronary vasodilators, intentional self-harm, sequela
        • T46.3X3 - Poisoning by coronary vasodilators, assault
          • T46.3X3A - Poisoning by coronary vasodilators, assault, initial encounter
          • T46.3X3D - Poisoning by coronary vasodilators, assault, subsequent encounter
          • T46.3X3S - Poisoning by coronary vasodilators, assault, sequela
        • T46.3X4 - Poisoning by coronary vasodilators, undetermined
          • T46.3X4A - Poisoning by coronary vasodilators, undetermined, initial encounter
          • T46.3X4D - Poisoning by coronary vasodilators, undetermined, subsequent encounter
          • T46.3X4S - Poisoning by coronary vasodilators, undetermined, sequela
        • T46.3X5 - Adverse effect of coronary vasodilators
          • T46.3X5A - Adverse effect of coronary vasodilators, initial encounter
          • T46.3X5D - Adverse effect of coronary vasodilators, subsequent encounter
          • T46.3X5S - Adverse effect of coronary vasodilators, sequela
        • T46.3X6 - Underdosing of coronary vasodilators
          • T46.3X6A - Underdosing of coronary vasodilators, initial encounter
          • T46.3X6D - Underdosing of coronary vasodilators, subsequent encounter
          • T46.3X6S - Underdosing of coronary vasodilators, sequela
    • T46.4 - Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors
      • T46.4X - Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors
        • T46.4X1 - Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional)
          • T46.4X1A - Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
          • T46.4X1D - Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter
          • T46.4X1S - Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela
        • T46.4X2 - Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm
          • T46.4X2A - Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter
          • T46.4X2D - Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter
          • T46.4X2S - Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela
        • T46.4X3 - Poisoning by angiotensin-converting-enzyme inhibitors, assault
          • T46.4X3A - Poisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter
          • T46.4X3D - Poisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter
          • T46.4X3S - Poisoning by angiotensin-converting-enzyme inhibitors, assault, sequela
        • T46.4X4 - Poisoning by angiotensin-converting-enzyme inhibitors, undetermined
          • T46.4X4A - Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter
          • T46.4X4D - Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter
          • T46.4X4S - Poisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela
        • T46.4X5 - Adverse effect of angiotensin-converting-enzyme inhibitors
          • T46.4X5A - Adverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
          • T46.4X5D - Adverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
          • T46.4X5S - Adverse effect of angiotensin-converting-enzyme inhibitors, sequela
        • T46.4X6 - Underdosing of angiotensin-converting-enzyme inhibitors
          • T46.4X6A - Underdosing of angiotensin-converting-enzyme inhibitors, initial encounter
          • T46.4X6D - Underdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter
          • T46.4X6S - Underdosing of angiotensin-converting-enzyme inhibitors, sequela
    • T46.5 - Poisoning by, adverse effect of and underdosing of other antihypertensive drugs
      • T46.5X - Poisoning by, adverse effect of and underdosing of other antihypertensive drugs
        • T46.5X1 - Poisoning by other antihypertensive drugs, accidental (unintentional)
          • T46.5X1A - Poisoning by other antihypertensive drugs, accidental (unintentional), initial encounter
          • T46.5X1D - Poisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounter
          • T46.5X1S - Poisoning by other antihypertensive drugs, accidental (unintentional), sequela
        • T46.5X2 - Poisoning by other antihypertensive drugs, intentional self-harm
          • T46.5X2A - Poisoning by other antihypertensive drugs, intentional self-harm, initial encounter
          • T46.5X2D - Poisoning by other antihypertensive drugs, intentional self-harm, subsequent encounter
          • T46.5X2S - Poisoning by other antihypertensive drugs, intentional self-harm, sequela
        • T46.5X3 - Poisoning by other antihypertensive drugs, assault
          • T46.5X3A - Poisoning by other antihypertensive drugs, assault, initial encounter
          • T46.5X3D - Poisoning by other antihypertensive drugs, assault, subsequent encounter
          • T46.5X3S - Poisoning by other antihypertensive drugs, assault, sequela
        • T46.5X4 - Poisoning by other antihypertensive drugs, undetermined
          • T46.5X4A - Poisoning by other antihypertensive drugs, undetermined, initial encounter
          • T46.5X4D - Poisoning by other antihypertensive drugs, undetermined, subsequent encounter
          • T46.5X4S - Poisoning by other antihypertensive drugs, undetermined, sequela
        • T46.5X5 - Adverse effect of other antihypertensive drugs
          • T46.5X5A - Adverse effect of other antihypertensive drugs, initial encounter
          • T46.5X5D - Adverse effect of other antihypertensive drugs, subsequent encounter
          • T46.5X5S - Adverse effect of other antihypertensive drugs, sequela
        • T46.5X6 - Underdosing of other antihypertensive drugs
          • T46.5X6A - Underdosing of other antihypertensive drugs, initial encounter
          • T46.5X6D - Underdosing of other antihypertensive drugs, subsequent encounter
          • T46.5X6S - Underdosing of other antihypertensive drugs, sequela
    • T46.6 - Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
      • T46.6X - Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
        • T46.6X1 - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional)
          • T46.6X1A - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter
          • T46.6X1D - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounter
          • T46.6X1S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela
        • T46.6X2 - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm
          • T46.6X2A - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter
          • T46.6X2D - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter
          • T46.6X2S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela
        • T46.6X3 - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault
          • T46.6X3A - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounter
          • T46.6X3D - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounter
          • T46.6X3S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequela
        • T46.6X4 - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined
          • T46.6X4A - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, initial encounter
          • T46.6X4D - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounter
          • T46.6X4S - Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequela
        • T46.6X5 - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs
          • T46.6X5A - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
          • T46.6X5D - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
          • T46.6X5S - Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
        • T46.6X6 - Underdosing of antihyperlipidemic and antiarteriosclerotic drugs
          • T46.6X6A - Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
          • T46.6X6D - Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
          • T46.6X6S - Underdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela
    • T46.7 - Poisoning by, adverse effect of and underdosing of peripheral vasodilators
      • T46.7X - Poisoning by, adverse effect of and underdosing of peripheral vasodilators
        • T46.7X1 - Poisoning by peripheral vasodilators, accidental (unintentional)
          • T46.7X1A - Poisoning by peripheral vasodilators, accidental (unintentional), initial encounter
          • T46.7X1D - Poisoning by peripheral vasodilators, accidental (unintentional), subsequent encounter
          • T46.7X1S - Poisoning by peripheral vasodilators, accidental (unintentional), sequela
        • T46.7X2 - Poisoning by peripheral vasodilators, intentional self-harm
          • T46.7X2A - Poisoning by peripheral vasodilators, intentional self-harm, initial encounter
          • T46.7X2D - Poisoning by peripheral vasodilators, intentional self-harm, subsequent encounter
          • T46.7X2S - Poisoning by peripheral vasodilators, intentional self-harm, sequela
        • T46.7X3 - Poisoning by peripheral vasodilators, assault
          • T46.7X3A - Poisoning by peripheral vasodilators, assault, initial encounter
          • T46.7X3D - Poisoning by peripheral vasodilators, assault, subsequent encounter
          • T46.7X3S - Poisoning by peripheral vasodilators, assault, sequela
        • T46.7X4 - Poisoning by peripheral vasodilators, undetermined
          • T46.7X4A - Poisoning by peripheral vasodilators, undetermined, initial encounter
          • T46.7X4D - Poisoning by peripheral vasodilators, undetermined, subsequent encounter
          • T46.7X4S - Poisoning by peripheral vasodilators, undetermined, sequela
        • T46.7X5 - Adverse effect of peripheral vasodilators
          • T46.7X5A - Adverse effect of peripheral vasodilators, initial encounter
          • T46.7X5D - Adverse effect of peripheral vasodilators, subsequent encounter
          • T46.7X5S - Adverse effect of peripheral vasodilators, sequela
        • T46.7X6 - Underdosing of peripheral vasodilators
          • T46.7X6A - Underdosing of peripheral vasodilators, initial encounter
          • T46.7X6D - Underdosing of peripheral vasodilators, subsequent encounter
          • T46.7X6S - Underdosing of peripheral vasodilators, sequela
    • T46.8 - Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents
      • T46.8X - Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents
        • T46.8X1 - Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional)
          • T46.8X1A - Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter
          • T46.8X1D - Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter
          • T46.8X1S - Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela
        • T46.8X2 - Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm
          • T46.8X2A - Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter
          • T46.8X2D - Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter
          • T46.8X2S - Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela
        • T46.8X3 - Poisoning by antivaricose drugs, including sclerosing agents, assault
          • T46.8X3A - Poisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter
          • T46.8X3D - Poisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter
          • T46.8X3S - Poisoning by antivaricose drugs, including sclerosing agents, assault, sequela
        • T46.8X4 - Poisoning by antivaricose drugs, including sclerosing agents, undetermined
          • T46.8X4A - Poisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter
          • T46.8X4D - Poisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter
          • T46.8X4S - Poisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela
        • T46.8X5 - Adverse effect of antivaricose drugs, including sclerosing agents
          • T46.8X5A - Adverse effect of antivaricose drugs, including sclerosing agents, initial encounter
          • T46.8X5D - Adverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
          • T46.8X5S - Adverse effect of antivaricose drugs, including sclerosing agents, sequela
        • T46.8X6 - Underdosing of antivaricose drugs, including sclerosing agents
          • T46.8X6A - Underdosing of antivaricose drugs, including sclerosing agents, initial encounter
          • T46.8X6D - Underdosing of antivaricose drugs, including sclerosing agents, subsequent encounter
          • T46.8X6S - Underdosing of antivaricose drugs, including sclerosing agents, sequela
    • T46.9 - Poisoning by, adverse effect of and underdosing of other and unspecified agents primarily affecting the cardiovascular system
      • T46.90 - Poisoning by, adverse effect of and underdosing of unspecified agents primarily affecting the cardiovascular system
        • T46.901 - Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional)
          • T46.901A - Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
          • T46.901D - Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
          • T46.901S - Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
        • T46.902 - Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm
          • T46.902A - Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
          • T46.902D - Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
          • T46.902S - Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela
        • T46.903 - Poisoning by unspecified agents primarily affecting the cardiovascular system, assault
          • T46.903A - Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter
          • T46.903D - Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter
          • T46.903S - Poisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela
        • T46.904 - Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined
          • T46.904A - Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter
          • T46.904D - Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
          • T46.904S - Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela
        • T46.905 - Adverse effect of unspecified agents primarily affecting the cardiovascular system
          • T46.905A - Adverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
          • T46.905D - Adverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
          • T46.905S - Adverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
        • T46.906 - Underdosing of unspecified agents primarily affecting the cardiovascular system
          • T46.906A - Underdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter
          • T46.906D - Underdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
          • T46.906S - Underdosing of unspecified agents primarily affecting the cardiovascular system, sequela
      • T46.99 - Poisoning by, adverse effect of and underdosing of other agents primarily affecting the cardiovascular system
        • T46.991 - Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional)
          • T46.991A - Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
          • T46.991D - Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
          • T46.991S - Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
        • T46.992 - Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm
          • T46.992A - Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
          • T46.992D - Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
          • T46.992S - Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela
        • T46.993 - Poisoning by other agents primarily affecting the cardiovascular system, assault
          • T46.993A - Poisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter
          • T46.993D - Poisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounter
          • T46.993S - Poisoning by other agents primarily affecting the cardiovascular system, assault, sequela
        • T46.994 - Poisoning by other agents primarily affecting the cardiovascular system, undetermined
          • T46.994A - Poisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter
          • T46.994D - Poisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
          • T46.994S - Poisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela
        • T46.995 - Adverse effect of other agents primarily affecting the cardiovascular system
          • T46.995A - Adverse effect of other agents primarily affecting the cardiovascular system, initial encounter
          • T46.995D - Adverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
          • T46.995S - Adverse effect of other agents primarily affecting the cardiovascular system, sequela
        • T46.996 - Underdosing of other agents primarily affecting the cardiovascular system
          • T46.996A - Underdosing of other agents primarily affecting the cardiovascular system, initial encounter
          • T46.996D - Underdosing of other agents primarily affecting the cardiovascular system, subsequent encounter
          • T46.996S - Underdosing of other agents primarily affecting the cardiovascular system, sequela

Note: The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes are developed and maintained by the Centers for Disease Control and Prevention (CDC). CDC's National Center for Health Statistics (NCHS) is responsible for the clinical modification of ICD-10 for use in the United States. The World Health Organization (WHO), which owns and publishes ICD-10, authorized NCHS to develop ICD-10-CM. All modifications to ICD-10 must conform to WHO's established ICD structure and conventions. All rights are reserved by the respective entities.